Supportive Care in Cancer

, Volume 14, Issue 6, pp 566–572

Amifostine in the management of radiation-induced and chemo-induced mucositis

  • Rene-Jean Bensadoun
  • Mark M. Schubert
  • Rajesh V. Lalla
  • Dorothy Keefe
Review Article



Mucositis is a significant complication of cancer therapy, with important clinical and economic implications. In June 2005, the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) conducted an evidence-based update review of the literature on mucositis. The goal of this literature review is to update previously published guidelines for the management of mucositis.


This article reports the findings of the subgroup charged with reviewing the literature related to amifostine.


Amifostine Mucositis Radiotheraphy Chemotheraphy 

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Rene-Jean Bensadoun
    • 1
  • Mark M. Schubert
    • 2
  • Rajesh V. Lalla
    • 3
  • Dorothy Keefe
    • 4
  1. 1.Department of Radiation OncologyCentre Antoine-LacassagneNiceFrance
  2. 2.Department of Oral MedicineUniversity of Washington, Oral Medicine Service, Seattle Cancer Care AllianceSeattleUSA
  3. 3.Department of Oral Health and Diagnostic Sciences MC1605University of Connecticut Health CenterFarmingtonUSA
  4. 4.Department of MedicineUniversity of AdelaideAdelaideSouth Australia

Personalised recommendations